Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSI-TNT: Psilocybin Therapy for Treatment Resistant Depression
NCT07211438Phase 2Recruiting
- Sponsor
- Center for Addiction and Mental Health
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in treatment-resistant depression (TRD), sponsored by Center for Addiction and Mental Health. Started Jul 2026; status: recruiting.
02
Drugs
psilocybin
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT07211438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07211438.